John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP), sold 19,542 shares at $0.59 ($11K) on 2025-01-13, disclosed to the SEC on 2025-01-15.
Seasonal sale ($11k) by Chief Patient Supply Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.59 | 4,268 | $3K | 22.2% |
| 2 | $0.59 | 5,471 | $3K | 28.5% |
| 3 | $0.57 | 9,803 | $6K | 49.3% |
| Total | $0.58 avg | 19,542 | $11K | 100% |
| Filing → |
| ADAP | SELL | 2024-01-12 | $8K | — | Filing → |
| ADAP | SELL | 2023-08-01 | $3K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $8K | — | Filing → |